Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2 is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 250 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI150241
NIAID NIH HHS
Grant: T32 AI055400
NIAID NIH HHS
Grant: R01 AI140539
NIAID NIH HHS
Grant: R01 AI150246
NIAID NIH HHS
Grant: R01 AI152362
National Institutes of Health
Grant: 1R01AI140539-01
Defining the functional interface between the ER and flaviviruses
National Institutes of Health
Grant: 1R01AI152362-01
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.
Burroughs Wellcome Fund
National Institutes of Health
FWCI
16.37
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals